The Eindhoven neurotechnology company is using the proceeds to fund its Empower BP pivotal trial, which tests whether its implantable ARC-IM® system can treat blood pressure instability after spinal cord injury, while expanding commercial rollout of its already-cleared ARC-EX® external therapy system. Cash runway now extends to Q1 2028. ONWARD Medical has raised €40.6 million […]
This story continues at The Next WebRead More